Inhibition of erythromycin lactobionate-induced writhing by analgesic drugs
Vinardell, P.; Planas, J.; Torralba, A.
Il Farmaco; Edizione Pratica 35(3): 133-140
1980
ISSN/ISBN: 0430-0912 PMID: 7439353 Document Number: 161562
Document emailed within 1 workday
Related Documents
Kane, M.P.; Bailie, G.R.; Moon, D.G.; Siu, I.; Eisele, G. 1994: Stability of erythromycin lactobionate in peritoneal dialysate solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 14(1): 79-81Warter, A.; Schirardin, H.; Warter, J. 1989: Activation in vivo of the collagenase of Clostridium histolyticum by erythromycin lactobionate Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 183(2): 153-156
Mineo, T.C.; Cristino, B.; Ambrogi, V.; Reggio, S. 1989: Short-term prophylaxis with erythromycin lactobionate in patients undergoing lung surgery Minerva Chirurgica 44(22): 2337-2340
Lester, G.D.; Merritt, A.M.; Neuwirth, L.; Vetro-Widenhouse, T.; Steible, C.; Rice, B. 1998: Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies American Journal of Veterinary Research 59(3): 328-334
Gyires, K.; Knoll, J. 1975: Inflammation and writhing syndrome inducing effect of PGE1, PGE2 and the inhibition of these actions Polish Journal of Pharmacology and Pharmacy 27(3): 257-264
Luo, X.; Lv, F.; Peng, M. 2017: Analgesic effect of different dosage of Flurbiprofen axetil in laparoscopic cholecystectomy in comparison with other analgesic drugs Pakistan Journal of Pharmaceutical Sciences 30(5(Special): 1895-1898
Karakaya, G.; Demir, A.U.; Kalyoncu, A.F. 2000: From analgesic intolerance to analgesic induced asthma: are there some determinants? Allergologia et Immunopathologia 28(4): 229-237
Snell, L.D.; Johnson, K.M. 1986: Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs Journal of Pharmacology and Experimental Therapeutics 238(3): 938-946
Kamei, C.; Sugimoto, Y.; Ohishi, H.; Okumura, Y.; Kitazumi, K. 1996: Epileptogenic activity induced by combined treatment with antiinflammatory drugs and enoxacin and its inhibition by a calcium antagonist, nicardipine Methods and Findings in Experimental and Clinical Pharmacology 18(9): 579-588
de Tinguy-Moreaud, E.; Pourquier, P.; Montaudon, D.; Robert, J. 1994: Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells Anticancer Research 14(1a): 99-103
Dunn, S.E.; Hardman, R.A.; Kari, F.W.; Barrett, J.C. 1997: Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs Cancer Research 57(13): 2687-2693
Fasulo, M.P.; Bassi, M.; Dall'Olio, G. 1981: Effects of erythromycin on Euglena gracilis as a model for testing the toxicity of antibacterial drugs Arzneimittel-Forschung 31(11): 1869-1872
Venho, V.M.; Palva, E.S.; Konno, K.; Stenfors, E. 1987: The value of comparative bioavailability studies of marketed drugs in drug control. An example with erythromycin stearate Methods and Findings in Experimental and Clinical Pharmacology 9(7): 445-447
Akl, K.; Dawod, S.T. 1994: Erythromycin-induced abdominal pain British Journal of Clinical Practice 48(1): 56
Yamazaki, H.; Shimada, T. 1998: Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1053-1057
Majer, J.; Stanaszek, R.S.; Mueller, S.L.; Marti, G. 1978: N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(6): 673-676
Klita, S.; Szafranśki, P. 1980: Comparison of the mechanism of action of cyclic 11,12-erythromycin a carbonate and erythromycin a Acta Biochimica Polonica 27(3-4): 213-220
Gafter, U.; Mandel, E.M.; Weiss, S.; Djaldetti, M. 1979: Erythromycin estolate-induced hepatitis. Ultrastructural study of liver New York State Journal of Medicine 79(1): 87-89
Pippi, N.L.; Lumb, W.V. 1979: Objective tests of analgesic drugs in ponies American Journal of Veterinary Research 40(8): 1082-1086
Jelić-Ivanović, Z.; Majkić-Singh, N.; Spasić, S.; Todorović, P.; Stakić, D.Z. 1983: Effect of analgesic and antirheumatic drugs on SMA Ii procedures Clinical Chemistry 29(10): 1859